-
Phosbind Biotin LC: Western Blot Guide
2026-09-18
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes, providing an alternative to phospho-specific antibodies. It is suited to Western blot workflows using streptavidin-HRP and chemiluminescence, but it should not be used in aqueous-only protocols or retained as a long-term working solution.
-
SW033291: A Translational 15-PGDH Strategy
2026-09-18
A mechanistic and translational perspective on SW033291, linking 15-PGDH inhibition and prostaglandin E2 elevation to hematopoiesis, tissue repair, and emerging muscle-regeneration strategies during semaglutide-associated weight loss.
-
LG 101506: From RXR Biology to Translation
2026-09-17
A thought-leadership analysis of LG 101506 as an RXR modulator for connecting nuclear receptor mechanism, cancer immunology, and translational experimental design without overstating the current evidence.
-
15-PGDH Inhibition Supports Muscle Repair During Weight Loss
2026-09-17
A 2026 PNAS study identifies 15-PGDH inhibition as a strategy for improving skeletal muscle regeneration and force recovery during semaglutide-associated weight loss in obese mice. The work suggests that combining a 15-PGDH inhibitor with GLP-1 receptor agonist therapy can preserve weight-loss efficacy while improving muscle stem cell activity, regenerated myofiber growth, and postinjury muscle quality.
-
Cyclosporin Variants and Mitochondrial Pore Activity
2026-09-16
The reference study combines NMR spectroscopy, molecular dynamics, and calcium-dependent mitochondrial swelling to explain why closely related cyclosporin congeners differ in mitochondrial pore activity. Its central finding is that greater peptide-backbone flexibility is associated with activity, whereas the comparatively rigid Cyclosporin E lacks detectable pore-inhibitory effects under the tested conditions.
-
Imipenem: From PBP Biology to Resistance Strategy
2026-09-16
A translational strategy for using Imipenem to connect PBP biology, carbapenemase dissemination, immune response modulation, and sepsis animal model design.
-
CTCF, Centromeres, and Mitotic Fidelity
2026-09-15
The reference study uses rapid, inducible CTCF degradation to show that CTCF maintains centromere function during mitosis rather than simply recruiting the CENP-E chromosome-congression motor. Loss of CTCF produces wider, disorganized metaphase plates, increased intercentromere distances, mitotic failure, and abnormal post-mitotic nuclear shape, providing a framework for separating centromere-maintenance defects from motor-dependent alignment phenotypes.
-
Bestatin (Ubenimex): From Enzyme Tool to Translation
2026-09-15
A translational guide to Bestatin (Ubenimex) that connects selective aminopeptidase inhibition with proteostasis, apoptosis assay design, multidrug resistance research, and more rigorous cancer research decisions.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-14
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR/mTOR pathway inhibitors at substantially lower concentrations than a wild-type background. The system recovered activity from established TOR inhibitors, identified aminophylline as a TOR1-dependent growth inhibitor, and found no evidence of TOR inhibition for Canagliflozin under the tested yeast conditions.
-
Estradiol Benzoate: ERα Assay Workflows
2026-09-14
Build more reproducible estrogen receptor experiments with a high-affinity ERα agonist, controlled solvent handling, and orthogonal validation. This guide translates Estradiol Benzoate specifications into practical binding, reporter, and troubleshooting workflows while separating established product data from assay recommendations.
-
SW033291: Practical 15-PGDH Inhibitor Workflows
2026-09-13
SW033291 enables controlled 15-PGDH inhibition for linking prostaglandin E2 elevation with hematopoiesis, muscle repair, and broader tissue regeneration research. This workflow-focused guide covers assay setup, translational interpretation, and troubleshooting from enzyme screens through cellular validation.
-
Lyso-Tracker Red: Reading Lysosomal Stress
2026-09-12
Lyso-Tracker Red enables lysosome labeling in live cells while preserving the physiological context needed to study lysosomal membrane permeability. This guide connects probe behavior with the SGI-1027–everolimus renal cancer study and shows how to distinguish lysosome localization from lysosomal damage.
-
From Nuclear Counts to Mitochondrial Quality Control
2026-09-11
A translational framework for using Hoechst 33342 nuclear staining to strengthen fibroblast senescence studies, interpret pterostilbene biology, and connect imaging readouts with mitochondrial quality control.
-
Optimizing hiPSC-Derived Platelet Production
2026-09-11
A 2026 study developed an optimized differentiation scheme that increases megakaryocyte and platelet production from human induced pluripotent stem cells while shortening culture time and reducing cost. Its integrated use of embryoid-body input, human platelet lysate, and small-molecule modulation offers a practical framework for more scalable production of functional platelets.
-
Annexin V-Cy5/DAPI Apoptosis Kit Guide
2026-09-10
The Annexin V-Cy5/DAPI Apoptosis Kit is a rapid apoptosis detection kit that combines phosphatidylserine binding with DNA staining. Its dual-parameter readout helps distinguish viable, apoptotic, and membrane-compromised cells in microscopy or flow-cytometry workflows.